IP Library › Granted Patent US 12,011,382
Granted Patent B2
US 12,011,382 · App. 17/571,756 · Granted Jun 18, 2024

Cervical collar

Inventor: Robert Michael Maher (Columbus, OH)
Assignee: NEURORESCUE, INC.
A61F5/055A61F7/0085A61F7/10A61F2007/0012A61F2007/0056A61F2007/0095A61F2007/0228A61F2007/0273
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,011,382
App. No.
17/571,756
Granted
Jun 18, 2024
Kind
B2
Abstract

A cervical collar that facilitates therapeutic hypothermia is provided and includes a cooling device having a front portion and a back portion fixedly coupled to the front portion on one side and removably coupled to the front portion on an opposite side. A fastening device removably couples the back portion to the front portion on the opposite side. The cooling device induces hypothermia in at least a portion of a patient. A sensor is provided that measures a physical characteristic of the patient.

Claims (31)

1. A system that facilitates comfort of a user via temperature modulation, comprising:

a neck wrap that includes a bladder having a chamber configured to retain a temperature altering substance, wherein the bladder at least partially encloses a neck region of the user;

the temperature altering substance that is provided at a pre-determined temperature; and

wherein the system selectively targets a portion of the neck region of the user thereby altering a temperature of the portion of the neck region of the user via the temperature altering sub stance.

2. The system of claim 1 , wherein the system further comprises at least one passageway that fluidly connects the chamber with a heating/cooling source.

3. The system of claim 2 , wherein the passageway further includes at least one inlet port and at least one outlet port that provide a connection between the heating/cooling source and the chamber.

4. The system of claim 3 , wherein the heating/cooling source comprises a first portable temperature control pack comprising the temperature altering substance.

5. The system of claim 4 , wherein the first portable temperature control pack is connected to the at least one inlet port and wherein the temperature altering substance may enter into the chamber via the at least one inlet port.

6. The system of claim 1 wherein at least a portion of the bladder is at least semi-transparent enabling a visual inspection of the temperature altering substance within the chamber.

7. The system of claim 6 wherein the temperature altering substance changes color in accordance with a temperature.

8. The system of claim 7 , wherein the temperature is a temperature of the portion of the neck region of the user.

9. The system of claim 1 , further comprising a temperature color changeable tag fixedly attached to the neck wrap, wherein the tag is configured to change color corresponding to a change of a temperature of the portion of the neck region of the user or the temperature altering sub stance.

10. The system of claim 1 , wherein the temperature altering substance is mechanically pumped or manually squeezed through an inlet port of the bladder and into the chamber.

11. A therapeutic device comprising:

an outer surface and an inner surface forming a cavity therebetween;

a chamber disposed within the cavity between the outer surface and the inner surface, wherein the chamber is configured to retain fluid, wherein the therapeutic device at least partially encloses a neck region of a user; and

wherein the chamber selectively targets blood flowing through cerebral vasculature thereby altering a temperature of the blood flowing through the cerebral vasculature to a modulate temperature of a user.

12. The therapeutic device of claim 11 , further comprising an indicator that changes color based on a change in a measurable event.

13. The therapeutic device of claim 12 , wherein the indicator is the chamber.

14. The therapeutic device of claim 13 , wherein at least a portion of the therapeutic device is at least semi-transparent enabling a visual inspection of the chamber.

15. The therapeutic device of claim 13 , wherein the chamber is segmented and connected by a passageway, wherein the passageway provides a connection between a portable fluid source and at least one segment of the chamber.

16. The therapeutic device of claim 12 , wherein the indicator is a tag fixedly attached to the therapeutic device.

17. A method of therapeutically modulating body temperature or a user, comprising:

placing a fluid-filled wrap on a neck region of the user, the wrap comprising a bladder configured to retain a fluid and to selectively contact specific portions of the neck region;

monitoring a temperature of the fluid inside the bladder; and

indicating the temperature via a visual indicator.

18. The method of claim 17 further comprising:

determining a target region of the user's neck; and

configuring the wrap to contact the target region.

19. The method of claim 17 , wherein the wrap comprises an indicator that changes color based on a change in a measurable event.

20. The method of claim 17 , wherein the indicator is the bladder, and wherein at least a portion of the wrap is at least semi-transparent enabling a visual inspection of the bladder.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 10, 2022
From: MAHER, ROBERT MICHAEL
To: NEURORESCUE, INC.
Reel/Frame 058605/0230 →
Continuity (9)
Continuation 16528046 · Jul 31, 2019
Continuation 16528090 · Jul 31, 2019
Continuation In Part 15287227 · Oct 6, 2016
Continuation In Part 15287227 · Oct 6, 2016
Continuation In Part 14052346 · Oct 11, 2013
Continuation In Part 13309173 · Dec 1, 2011
Provisional Application 62834781 · Apr 16, 2019
Provisional Application 61419018 · Dec 2, 2010
Related Publication 20220125615A1 · Apr 28, 2022
Cited By (2)
US 12,419,771 US 12,533,255